Multiple Sclerosis International / 2011 / Article / Tab 2 / Research Article
The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis Table 2 Patient characteristics: MS patients diagnosed with depression but untreated compared to MS patients diagnosed with depression who received an antidepressant.
Characteristic
Dx Depression (
)
Dx & Rx Depression (
)
statistic
value
%
% Characteristics matched on Age N/A N/A <35 1 2.63 1 2.63 35–44 8 21.04 8 21.04 45–54 19 50.00 19 50.00 55–64 10 26.32 10 26.32 65+ 0 0 0 0 Sex N/A N/A Male 2 5.26 2 5.26 Female 36 94.74 36 94.74 Region N/A N/A Northeast 3 7.89 3 7.89 North Central 13 34.21 13 34.21 South 12 31.58 12 31.58 West 10 26.32 10 26.32 Unknown 0 0 0 0 Year of index date N/A N/A 2004 6 15.79 6 15.79 2005 11 28.95 11 28.95 2006 10 26.32 10 26.32 2007 10 26.32 10 26.32 2008 1 2.63 1 2.63 ITT DMT N/A N/A Avonex 12 31.58 12 31.58 Betaseron 2 5.26 2 5.26 Copaxone 19 50.00 19 50.00 Rebif 4 10.53 4 10.53 Tysabri 1 2.63 1 2.63 Other characteristics Insurance status Comprehensive 6 15.79 4 13.16 0.11 0.744 Health maintenance org 5 13.16 9 23.68 1.40 0.236 Point-of-service 6 15.79 7 18.42 0.93 0.761 Preferred provider org 20 52.63 16 42.11 0.84 0.358 Other 1 2.63 1 2.63 N/A N/A Copayment with ITT drug 29 76.32 29 76.32 N/A N/A Mail order for ITT drug 13 34.21 10 26.32 0.56 0.454 Preperiod Charlson score 0 23 60.53 21 55.26 0.22 0.642 1-2 11 28.95 15 39.47 0.93 0.334 3+ 4 10.53 2 5.26 0.72 0.395 Preperiod disability proxies Muscoloskeletal 25 65.79 24 63.16 0.06 0.811 Medical 16 42.11 18 47.37 0.22 0.645